Xylazine is a non-opioid veterinary sedative that’s infiltrated the illicit drug supply as a cheap bulking agent for fentanyl, earning the street name “tranq.” It depresses your central nervous system by activating alpha-2 adrenergic and kappa opioid receptors, causing prolonged sedation, respiratory depression, and dangerous drops in heart rate, underscoring the need for tianeptine addiction treatment. Because it operates outside traditional opioid pathways, naloxone can’t reverse its effects, highlighting xylazine vs fentanyl. Understanding how tranq damages tissue, complicates overdoses, and interacts with fentanyl can help you recognize the dangers ahead, reflecting emerging trends in substance abuse.
What Is Xylazine and Why Is It Called “Tranq”?
